Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
NCT02101606
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Cerebral Infarction
Brain Ischemia
Stroke
Interventions
DRUG:
Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Sponsor
University of Alberta